Long-term drug therapy and drug holidays for osteoporosis fracture prevention: a systematic review
Fink HA, MacDonald R, Forte ML, Rosebush CE, Ensrud KE, Schousboe JT, Nelson VA, Ullman K, Butler M, Olson CM, Taylor BC, Brasure M, Wilt TJ
Record ID 32018005021
English
Details
Project Status:
Completed
Year Published:
2019
URL for published report:
https://effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Osteoporosis
- Drug Therapy
- Alendronate
- Bone Density Conservation Agents
- Diphosphonates
- Osteoporosis, Postmenopausal
- Zoledronic Acid
- Duration of Therapy
- Drug Administration Schedule
- Hip Fractures
- Spinal Fractures
Keywords
- Female
- Femur Neck
- Bone Density
- Quality of Life
- Osteoporosis
- Pharmacological treatment
- Wounds and Injuries
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
<p>Agency for Health Care Research and Quality (AHRQ)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.